Standard
Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark. / Christiansen, Peer Michael; Bjerre, Karsten; Ejlertsen, Bent; Jensen, Maj-Britt; Rasmussen, Birgitte B; Lænkholm, Anne-Vibeke; Kroman, Niels; Ewertz, Marianne; Offersen, Birgitte Vrou; Toftdahl, Dorte B; Møller, Susanne; Mouridsen, Henning T; Danish Breast Cancer Cooperative Group.
I:
National Cancer Institute. Journal (Print), Bind 103, Nr. 18, 2011, s. 1363-72.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Christiansen, PM, Bjerre, K, Ejlertsen, B, Jensen, M-B, Rasmussen, BB, Lænkholm, A-V
, Kroman, N, Ewertz, M, Offersen, BV, Toftdahl, DB, Møller, S, Mouridsen, HT & Danish Breast Cancer Cooperative Group 2011, '
Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark',
National Cancer Institute. Journal (Print), bind 103, nr. 18, s. 1363-72.
https://doi.org/10.1093/jnci/djr299APA
Christiansen, P. M., Bjerre, K., Ejlertsen, B., Jensen, M-B., Rasmussen, B. B., Lænkholm, A-V.
, Kroman, N., Ewertz, M., Offersen, B. V., Toftdahl, D. B., Møller, S., Mouridsen, H. T., & Danish Breast Cancer Cooperative Group (2011).
Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
National Cancer Institute. Journal (Print),
103(18), 1363-72.
https://doi.org/10.1093/jnci/djr299Vancouver
Christiansen PM, Bjerre K, Ejlertsen B, Jensen M-B, Rasmussen BB, Lænkholm A-V o.a.
Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
National Cancer Institute. Journal (Print). 2011;103(18):1363-72.
https://doi.org/10.1093/jnci/djr299Author
Christiansen, Peer Michael ; Bjerre, Karsten ; Ejlertsen, Bent ; Jensen, Maj-Britt ; Rasmussen, Birgitte B ; Lænkholm, Anne-Vibeke ; Kroman, Niels ; Ewertz, Marianne ; Offersen, Birgitte Vrou ; Toftdahl, Dorte B ; Møller, Susanne ; Mouridsen, Henning T ; Danish Breast Cancer Cooperative Group. / Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark. I: National Cancer Institute. Journal (Print). 2011 ; Bind 103, Nr. 18. s. 1363-72.
Bibtex
@article{801e008081ac4660b5992c9647753b21,
title = "Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark",
abstract = "Indications for adjuvant endocrine treatment of breast cancer have gradually increased over the past several years. We aimed to define subgroups of patients who may or may not benefit from adjuvant endocrine therapy.",
author = "Christiansen, {Peer Michael} and Karsten Bjerre and Bent Ejlertsen and Maj-Britt Jensen and Rasmussen, {Birgitte B} and Anne-Vibeke L{\ae}nkholm and Niels Kroman and Marianne Ewertz and Offersen, {Birgitte Vrou} and Toftdahl, {Dorte B} and Susanne M{\o}ller and Mouridsen, {Henning T} and Kroman, {Niels Thorndahl}",
year = "2011",
doi = "http://dx.doi.org/10.1093/jnci/djr299",
language = "English",
volume = "103",
pages = "1363--72",
journal = "National Cancer Institute. Journal (Print)",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "18",
}
RIS
TY - JOUR
T1 - Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark
AU - Christiansen, Peer Michael
AU - Bjerre, Karsten
AU - Ejlertsen, Bent
AU - Jensen, Maj-Britt
AU - Rasmussen, Birgitte B
AU - Lænkholm, Anne-Vibeke
AU - Kroman, Niels
AU - Ewertz, Marianne
AU - Offersen, Birgitte Vrou
AU - Toftdahl, Dorte B
AU - Møller, Susanne
AU - Mouridsen, Henning T
AU - Danish Breast Cancer Cooperative Group
PY - 2011
Y1 - 2011
N2 - Indications for adjuvant endocrine treatment of breast cancer have gradually increased over the past several years. We aimed to define subgroups of patients who may or may not benefit from adjuvant endocrine therapy.
AB - Indications for adjuvant endocrine treatment of breast cancer have gradually increased over the past several years. We aimed to define subgroups of patients who may or may not benefit from adjuvant endocrine therapy.
U2 - http://dx.doi.org/10.1093/jnci/djr299
DO - http://dx.doi.org/10.1093/jnci/djr299
M3 - Journal article
VL - 103
SP - 1363
EP - 1372
JO - National Cancer Institute. Journal (Print)
JF - National Cancer Institute. Journal (Print)
SN - 0027-8874
IS - 18
ER -
